Tyra Biosciences (TYRA) Interest Expenses (2020 - 2023)
Quarterly Interest Expenses rose 61.54% to $21000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $21000.0 through Mar 2024, down 59.62% year-over-year, with the annual reading at $39000.0 for FY2023, 22.0% down from the prior year.
Tyra Biosciences filings provide 4 years of Interest Expenses readings, the most recent being $21000.0 for Q2 2023.
- Interest Expenses hit $21000.0 in Q2 2023 for Tyra Biosciences, up from $1000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $33000.0 in Q4 2022 and bottomed at $1000.0 in Q1 2023.
- Average Interest Expenses over 4 years is $10363.6, with a median of $7000.0 recorded in 2020.
- The largest annual shift saw Interest Expenses surged 1000.0% in 2022 before it crashed 90.0% in 2023.
- Tyra Biosciences' Interest Expenses stood at $6000.0 in 2020, then tumbled by 50.0% to $3000.0 in 2021, then surged by 1000.0% to $33000.0 in 2022, then plummeted by 36.36% to $21000.0 in 2023.
- Per Business Quant, the three most recent readings for TYRA's Interest Expenses are $21000.0 (Q2 2023), $1000.0 (Q1 2023), and $33000.0 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 12.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -332,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Sep 30, 2020 | 7,000.00 |